Allied Investment Advisors LLC purchased a new position in shares of Amrize Ltd (NYSE:AMRZ – Free Report) during the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 196,078 shares of the company’s stock, valued at approximately $9,516,000.
Other institutional investors have also recently modified their holdings of the company. Allspring Global Investments Holdings LLC acquired a new stake in Amrize in the 2nd quarter valued at $62,646,000. Credit Industriel ET Commercial acquired a new stake in Amrize during the 2nd quarter worth about $109,000. TD Asset Management Inc bought a new position in shares of Amrize during the 2nd quarter valued at $8,190,000. Generali Asset Management SPA SGR acquired a new position in Amrize during the 2nd quarter worth $4,923,000. Finally, Allianz Asset Management GmbH bought a new stake in shares of Amrize in the second quarter valued at about $158,530,000.
Wall Street Analyst Weigh In
AMRZ has been the topic of a number of recent analyst reports. Oddo Bhf started coverage on Amrize in a report on Monday, November 3rd. They set a “neutral” rating on the stock. The Goldman Sachs Group set a $58.00 price target on shares of Amrize in a research report on Monday, January 12th. Wall Street Zen upgraded Amrize to a “hold” rating in a research note on Saturday, October 25th. Oppenheimer upped their price target on shares of Amrize from $62.00 to $64.00 and gave the company an “outperform” rating in a research note on Thursday, January 15th. Finally, Sanford C. Bernstein reissued an “outperform” rating and set a $70.00 price target on shares of Amrize in a research note on Thursday, December 18th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $60.75.
Insider Buying and Selling at Amrize
In related news, insider Jaime Hill purchased 4,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 4th. The shares were purchased at an average cost of $50.69 per share, with a total value of $202,760.00. Following the purchase, the insider owned 18,101 shares of the company’s stock, valued at $917,539.69. This represents a 28.37% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Nicholas C. Gangestad purchased 2,000 shares of the firm’s stock in a transaction dated Wednesday, November 19th. The stock was acquired at an average cost of $47.34 per share, for a total transaction of $94,680.00. Following the purchase, the director owned 4,958 shares in the company, valued at approximately $234,711.72. The trade was a 67.61% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure.
Amrize Stock Down 2.8%
Amrize stock opened at $52.64 on Monday. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.38. The company’s fifty day simple moving average is $54.24. The stock has a market capitalization of $29.11 billion and a P/E ratio of 28.61. Amrize Ltd has a 52-week low of $44.12 and a 52-week high of $58.11.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Further Reading
- Five stocks we like better than Amrize
- Trump just signed it
- Trump Devises the Death of the IRS ??
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- GOLD ALERT
- What Expenses Can Be Deducted From Capital Gains Tax?
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
